The Mississauga Support Group To Host Annual Fundraiser PDF Print E-mail
Thursday, 03 March 2011 22:41
The Mississauga Support Group of the Scleroderma Society of Ontario will host its annual fundraising dinner and dance gala on April 2 at the Oasis Convention Centre. Funds raised will go to the Scleroderma Society of Ontario to fund research, improve patient care and raise public awareness of the chronic, progressive autoimmune disease of the connective tissue, which generally causes a hardening of the skin.
Those living with the illness, which usually strikes women between the ages of 30 and 50, also experience poor circulation and skin discolouration, a hardening of internal organs, reduced finger function and difficulty with movement and swallowing. Since its inception, the gala has raised $236,000. This year's event will include a reception and raffle as well as live and silent auctions, plus dinner. Tickets cost $75 and come with a $50 charitable tax receipt. Call 905-822-7868, 905-990-4598, 905-826-3961 or 905-824-2305. Scleroderma affects hundreds of people in Ontario and about 16,000 across Canada.
Scleroderma Awareness Month takes place each June.
The Mississauga Support Group of the Scleroderma Society of Ontario will host its annual fundraising dinner and dance gala on April 2 at the Oasis Convention Centre. Funds raised will go to the Scleroderma Society of Ontario to fund research, improve patient care and raise public awareness of the chronic, progressive autoimmune disease of the connective tissue, which generally causes a hardening of the skin. Those living with the illness, which usually strikes women between the ages of 30 and 50, also experience poor circulation and skin discolouration, a hardening of internal organs, reduced finger function and difficulty with movement and swallowing.  

Since its inception, the gala has raised $236,000. This year's event will include a reception and raffle as well as live and silent auctions, plus dinner. Tickets cost $75 and come with a $50 charitable tax receipt. Call 905-822-7868, 905-990-4598, 905-826-3961 or 905-824-2305. Scleroderma affects hundreds of people in Ontario and about 16,000 across Canada. 

Scleroderma Awareness Month takes place each June.
 
More articles :

» What You Should Know About The AntiNuclear Antibody Or ANA Test

How is it used?The ANA test is ordered to help screen for autoimmune disorders and is most often used as one of the tests to diagnose (SLE). Depending on the patient's symptoms and the suspected diagnosis, ANA may be ordered along with one or more...

» Shyanne Adams Heading To London Courtesy Of The Make-A-Wish Foundation

It wasn't until Shyanne Adams started feeling better recently that she realized just how hard the past year has been. “I think I was in shock the whole year,” said the 14-year-old Eagle Valley Middle School eighth-grader. “I was depressed. I...

» New Research Findings May Bring Breakthrough For Scleroderma Patients

Research presented at the European Academy of Dermatology and Venereology in Prague, Czech Republic, suggests that inhibition of the may be a viable therapeutic target in patients.This finding builds on previous research by presenter and lead...

» Prevention Of Vascular Damage In Scleroderma With Angiotensin-converting Enzyme (ACE) Inhibition

Great strides have been made in identifying and managing the organ-based complications of  systemic sclerosis (SSc). There is no room for the nihilism towards treating this disease that used to be so prevalent. However, there is still...

» Scientists and Clinicians Address Diagnosis and Treatment for Autoimmune and Autoinflammatory Diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50...

» Systemic Sclerosis Sine Scleroderma

HADI POORMOGHIM, MARY LUCAS, NOREEN FERTIG, and THOMAS A. MEDSGER, JR.ARTHRITIS & RHEUMATISM Vol. 43, No. 2, February 2000, pp 444–451 © 2000, American College of RheumatologyObjectiveTo describe the demographic, clinical, and laboratory...